Investing in Scientific Discoveries
Leading scientific discoveries requires investing in and supporting early career investigators.
Why it matters:
Since 2004, the ATS Research Program's investment of more than $24M in early career researchers has leveraged well over $880 million in NIH funding and breakthroughs in respiratory medicine.
Investing in early career investigators is crucial for driving advancements in research and transforming patient care. The ATS also emphasizes the importance of cultivating partnerships in business, government, and academia to further support these developments.
The bottom line:
The ATS Research Program is dedicated to advancing scientific discovery and improving patient care in respiratory medicine.
Come together as a Society and support the ATS Research Program! Join us to kick off ATS 2025 at our annual networking fundraiser reception, the ATS Research Program Benefit.
The Benefit will be held on Saturday, May 17, 2025 from 6 – 7:30 p.m. at the San Francisco Marriott Marquis. Each ticket includes a tax-deductible donation to the ATS Research Program.